Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
current BCM postdocs, and learn about research, career development and support resources designed to help you reach your professional goals. Virtual Programming from the Office of Postdoctoral Affairs will
-
the representation of women in research, building research and clinical capacity, and rapidly translating findings into practice through integrated knowledge mobilization. “The ultimate goal is to train top-tier
-
metastatic progression. The Garner lab studies how changes in the bone marrow during myeloid cell development influence their function and contribute to disease progression. Our goal is to identify new
-
are: Create favourable circumstances for the development of a field of research and a community of research on access to justice for OLMCs Produce scientific data for and with the access to justice stakeholders
-
. Inclusive Innovator of the Year The Mitacs Inclusive Innovator of the Year Award celebrates the achievements of equity-deserving groups in developing and/or fostering an inclusive innovation ecosystem. It
-
innovation and scholarship of tomorrow to develop the skills to build world-class research and drive Canadian prosperity and competitiveness. Description The CPRA program is a federal research talent
-
of tomorrow to develop the skills to build world-class research and drive Canadian prosperity and competitiveness. Description The CPRA program is a federal research talent investment program in the Canada
-
evidence from diverse sources, analyze international survey data, and contribute to the development of a conceptual framework that captures the multi-level and intersectional nature of stigma. Findings from
-
: Department of Physics Position Summary: Development of a comprehensive phase field modelling platform for the quantitative examination of microstructure evolution and properties in two-phase Ferritie Steel and
-
tissue collection infrastructure, generate foundational single-cell and spatial omics datasets, and develop patient-tissue glioma organoid (PTGO) models to test immunotherapy strategies. The ultimate goal